The Journal of Clinical Oncology (JCO) is a medical journal published 3 times a month (36 issues a year) by the American Society of Clinical Oncology (ASCO), with a 2010 impact factor of 18.970. JCO now accounts for nearly one in 10 of all oncology journal citations. This journal s focus is work that relates to the care of patients with cancer, e.g., clinical oncology. This journal publishes in varying formats. Original research reports are both a communication tool and reports for original research. Review articles can describe work that builds on previous original research, summarize the current state clinical oncology, or can be a point of critical analysis. Opinion is voiced in editorial formats, which include commentary and discuss controversies. There is also a format for perspectives from a person of public notoriety. Special articles are another form of communication besides original research reports, which promulgate guidelines, summaries of consensus, and other scholarly communications. Fundamental research is covered in the "Biology of Neoplasia" section.
In a new study including Yale Cancer Center and Smilow Cancer Hospital researchers, the cancer immunotherapy drug pembrolizumab (Keytruda), increased survival for patients with advanced non-small cell lung cancer (NSCLC), ...
Jun 13, 2019
0
78
A new precision medicine targeting cancer's ability to repair its DNA has shown promising results in the first clinical trial of the drug class.
Jun 22, 2020
0
1108
Colorectal cancer patients who followed healthy diets had a lower risk of death from colorectal cancer and all causes, even those who improved their diets after being diagnosed, according to a new American Cancer Society ...
Oct 20, 2018
0
189
A pooled analysis of nine prospective studies involving more than 750,000 adults finds that recommended amounts of leisure-time physical activity were linked to a lower risk for seven cancers, with several cancer types having ...
Dec 26, 2019
0
921
New research suggests long-term, high-dose supplementation with vitamins B6 and B12—long touted by the vitamin industry for increasing energy and improving metabolism—is associated with a two- to four-fold increased lung ...
Aug 22, 2017
0
759
Surveillance programs for people at high risk of developing pancreatic cancers can help detect precancerous conditions and cancers early, when they are most treatable, according to a new multicenter study directed by experts ...
Jul 13, 2022
0
9
A recently published international clinical Phase III trial of a promising drug for treating advanced prostate cancer ended with surprising results: The new therapeutic agent failed to achieve any significant improvement ...
Jul 12, 2016
1
25
A gynecologic oncologist at the Stephenson Cancer Center at OU Medicine was a national leader of a newly published research study that reveals good news for women with ovarian cancer—longer survival times plus a treatment ...
May 3, 2019
0
538
An analysis by researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, found that cancer patients with privatized, cost-saving Medicare Advantage were more likely ...
Nov 21, 2022
0
61
Using the nation's largest COVID-19 data resource, a researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center found the COVID-19 vaccine protected most cancer patients from getting COVID. However, ...
Apr 4, 2022
0
62
